Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Policy

China moves to promote development of pharmaceutical industry

December 25, 2024


Abstract : Chinese Premier Li Qiang on Monday presided over a State Council executive meeting that approved a guideline on strictly regulating enterprise-related administrative inspections and made arrangements for further reform on the regulation of medicines and medical devices to promote the high-quality development of the pharmaceutical industry.

BEIJING, Dec. 24 (Xinhua) -- Chinese Premier Li Qiang on Monday presided over a State Council executive meeting that approved a guideline on strictly regulating enterprise-related administrative inspections and made arrangements for further reform on the regulation of medicines and medical devices to promote the high-quality development of the pharmaceutical industry.

Enterprise-related administrative inspections should be strictly regulated with a focus on stabilizing market expectations and improving law-based governance, according to the meeting, which noted that there had been arbitrary actions by certain localities and departments that impacted enterprises' operations and the business environment.

It said that inspection standards and procedures should be strictly enforced, and efforts should be made to strengthen oversight on administrative inspections, reduce the frequency of on-site inspections and eliminate arbitrary ones.

The meeting called for deepening the reform of the entire medicine and medical device regulation process to increase China's pharmaceutical strength and meet public demand for high-quality medicines and medical devices.

Work should be done to support the research and innovation of medicines and medical devices, improve the quality and efficiency of review and approval processes, enhance regulatory oversight, and support the pharmaceutical industry in seeking further opening-up and cooperation, according to the meeting.

It also studied enhancing regulatory capacity on all food safety links. It was briefed about the incentive and constraint mechanisms to promote high-quality development through transfer payments.

The meeting said that transfer payments should play a role in guiding local high-quality development, and the incentive funds should be tilted to regions with greater tax contributions and faster income growth.

The meeting approved draft rules on standardizing intermediaries' services for the public stock offerings of companies. 

Scan the QR code and push it to your mobile phone

Keyword: pharmaceutical industry

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial